<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00520377</url>
  </required_header>
  <id_info>
    <org_study_id>Scil-MD05-C01</org_study_id>
    <secondary_id>Sinus Lift Study</secondary_id>
    <nct_id>NCT00520377</nct_id>
  </id_info>
  <brief_title>Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation</brief_title>
  <official_title>Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Scil Technology GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>FGK Clinical Research GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Scil Technology GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is the area of newly formed bone (%) as assessed by histomorphometry
      with either MD05 or beta-TCP.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2005</start_date>
  <completion_date type="Anticipated">May 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area of newly formed mineralised bone tissue (%) as assessed by histomorphometry.</measure>
    <time_frame>Within 4 months after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>evidence of uncompromised healing</measure>
    <time_frame>January 2008</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Alveolar Ridge Augmentation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MD05</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Beta-TCP and autologous bone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MD05</intervention_name>
    <description>recombinant human GDF-5 coated onto beta-tricalcium phosphate</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Beta-TCP and autologous bone</intervention_name>
    <description>beta-tricalcium phosphate and autologous bone</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients requiring two-stage unilateral maxillary sinus floor augmentation (sinus
             lift) in case of insufficient bone height in the area of the posterior maxilla, prior
             to insertion of dental implants

          -  Residual bone height at the site of planned implantation &gt; 1 mm and &lt; 5 mm

          -  Male and female outpatients, 18 to 75 years old

          -  Female patients must be infertile (either sterilized or postmenopausal). If a
             patient's menopausal status at screening is uncertain, levels of follicle stimulating
             hormone (FSH) should be determined. Patients with an FSH level &gt; 25 IU/l and absence
             of menstrual bleeding &gt; 6 months will satisfy the definition of postmenopausal status.

          -  Patient has given informed consent.

        Exclusion Criteria:

          -  Women of childbearing potential, lactating women

          -  Participation in another clinical study within 30 days prior to study start

          -  Previous participation in this study

          -  Last dental extraction (maxilla, posterior to canine) within the last 3 months

          -  Failed sinus lift surgery and previous eradictive maxillary sinus surgery

          -  Simultaneously bilateral sinus lift

          -  Legal incompetence or restricted legal competence

          -  Alcoholism, drug dependency, smoking

          -  Acute or chronic infection at the application site, e.g., sinusitis

          -  Known infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), or
             hepatitis C virus (HCV)

          -  Severe allergic rhinitis which requires permanent medication (Rosenlicht 1999)

          -  Known intolerance of or hypersensitivity to beta-TCP or rhGDF﷓-5

          -  Presence of local or systemic malignant disease or history of local or systemic
             malignant disease in the past 5 years

          -  Patients requiring chemo- or radiotherapy

          -  Previous or current radiotherapy of the head

          -  Chronic liver disorder

          -  Impaired renal function

          -  Uncontrolled, insulin-dependent diabetes mellitus

          -  Clinically relevant symptoms of thyroid dysfunction

          -  Severe hypertension (RRdiast &gt; 110 mmHg);

          -  Clinically relevant cardiovascular disease

          -  Systemic bone disease or illness having influence on bone metabolism,

          -  Clinically relevant blood coagulation disorder,

          -  Leukopenia &lt; 3.500 leukocytes/µL

          -  Previous or current treatment with systemic corticosteroids

          -  Previous or current therapy with drugs having any influence on bone metabolism

          -  Previous or current treatment with immunosuppressant medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilfried Wagner, Prof Dr Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Mainz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinik Erlangen</name>
      <address>
        <city>Erlangen</city>
        <state>Bayern</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Gath</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IPI München GmbH</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>81925</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Schmidinger</name>
      <address>
        <city>Seefeld</city>
        <state>Bayern</state>
        <zip>82229</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <state>Nordrhein Westfalen</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <state>Rheinland Pflaz</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig Holstein</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinik</name>
      <address>
        <city>Erfurt</city>
        <state>Thüringen</state>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2007</study_first_submitted>
  <study_first_submitted_qc>August 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2007</study_first_posted>
  <last_update_submitted>April 22, 2008</last_update_submitted>
  <last_update_submitted_qc>April 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 23, 2008</last_update_posted>
  <responsible_party>
    <name_title>Björn Capsius</name_title>
    <organization>Scil Technology GmbH</organization>
  </responsible_party>
  <keyword>Sinus Lift Surgery</keyword>
  <keyword>Sinus Floor Augmentation</keyword>
  <keyword>Insufficient Bone Height</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

